<iframe src="//www.googletagmanager.com/ns.html?id=GTM-MX3DVL" height="0" width="0" style="display:none;visibility:hidden"></iframe>Pestalozzi advised Promethera Biosciences SA in connection with its acquisition of Baliopharm AG | Pestalozzi Attorneys at Law

Pestalozzi advised Promethera Biosciences SA in connection with its acquisition of Baliopharm AG

11.04.2018

On 10 April 2018, Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases based in Mont-Saint-Guibert, Belgium, announced that it has acquired Baliopharm AG, a Swiss biopharmaceutical company focused on the development of targeted biological therapies for immune mediated inflammatory diseseas and cancer. Pestalozzi advised Promethera on Swiss law aspects of this transaction.

The Pestalozzi team included:
Franz Schubiger (Partner - Corporate / M&A), Nils Harbeke (Partner - Tax), Christian Roos (Partner - Employment & Pensions), Severin Roelli (Partner - Corporate / M&A), Nikolaus Thaddaeus Paumgartner (Associate - Corporate / M&A)

To the top

Cookies

Close
We use cookies in order to optimally design and continuously improve our website. By continuing to use the website you consent to the use of cookies. For further information about cookies please view our data protection statement.